Orphazyme A/S buy me8
Start price
23.08.21
/
0%
€4.98
Target price
23.08.22
€7.00
Performance (%)
-17.27%
End price
04.09.21
€4.12
Summary
This prediction ended on 04.09.21 with a price of €4.12. The prediction for Orphazyme A/S disappointed with a performance of -17.27%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orphazyme A/S | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to me8 what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
Little innovation
Comments by me8 for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
Kursziel gesetzt auf 7,0
In the thread Trading Orphazyme A/s
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.